← Back to Search

Contraceptive Counseling for Gender Dysphoria

Phase 4

Recruiting

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up between 6 and 12 months of first dmpa administration

Awards & highlights

Study Summary

This trial aims to create best practices for contraceptive counseling for transgender youth, recognizing that their needs differ from cis-gender youth.

Who is the study for?

This trial is for transgender and gender diverse youth, assigned female at birth, aged 15-21, who are patients at certain clinics. It's for those currently using or interested in using the contraceptive Depo Medroxyprogesterone (DMPA). Those with health conditions that make DMPA unsafe based on CDC guidelines cannot participate.Check my eligibility

What is being tested?

The study aims to develop best practices for contraceptive counseling tailored to transgender and gender diverse adolescents. It involves focus groups and interviews with participants about their experiences with DMPA to improve satisfaction and counseling methods.See study design

What are the potential side effects?

While this study focuses on counseling rather than direct medical intervention, it should be noted that DMPA itself can have side effects such as changes in menstrual periods, weight gain, headaches, mood changes, or bone density loss over time.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ between 6 and 12 months of first dmpa administration

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~between 6 and 12 months of first dmpa administration

This trial's timeline: 3 weeks for screening, Varies for treatment, and between 6 and 12 months of first dmpa administration for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Satisfaction with DMPA Administered in an Office Setting

Satisfaction with Self-administered DMPA after two injections

Satisfaction with Self-administered DMPA at initiation

Trial Design

1Treatment groups

Experimental Treatment

Group I: Depo SC HomeExperimental Treatment1 Intervention

Participants will be given instructions on home administration of DMPA SC and be provided with all necessary supplies.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,738 Previous Clinical Trials

2,149,486 Total Patients Enrolled

2 Trials studying Gender Dysphoria

109 Patients Enrolled for Gender Dysphoria

Eva M Dindinger, MPHStudy ChairUniversity of Colorado, Denver

Media Library

Counseling Clinical Trial Eligibility Overview. Trial Name: NCT05726903 — Phase 4

Gender Dysphoria Research Study Groups: Depo SC Home

Gender Dysphoria Clinical Trial 2023: Counseling Highlights & Side Effects. Trial Name: NCT05726903 — Phase 4

Counseling 2023 Treatment Timeline for Medical Study. Trial Name: NCT05726903 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation open to individuals aged 45 and above?

"The participants of this trial must be between 15 and 21 years old."

Answered by AI

What potential health risks has Depo SC Home been linked to?

"Extensive evidence has been gathered, so Depo SC Home's safety score is 3. This pharmaceutical product holds a Phase 4 approval status from our team at Power."

Answered by AI

Is there availability for participants to join this research project?

"Clinicaltrials.gov data confirms that this trial is actively seeking participants to join. The first instance of the study being posted was on December 6th 2022, with its most recent update occurring in February 13th 2023."

Answered by AI

How many participants does this experimental trial currently accommodate?

"Affirmative. The details made available on clinicaltrials.gov reveal that this experiment is actively looking for recruits. It was first advertised on December 6th 2022 and has been updated as recently as February 13th 2023, with 40 participants sought from a single location."

Answered by AI

Could I be a contributor to this clinical experiment?

"This trial seeks to enrol 40 individuals who have gender dysphoria and fall between the ages of 15-21. Prospective participants must be receiving medical care at one of the designated sites, assigned female at birth, identify as transgender or gender diverse, and either be using depot medroxyprogesterone acetate (DMPA) or are interested in using it."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone

2022. "Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05726903.